NCT02606877View on ClinicalTrials.gov

A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination

PHASE4CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

April 19, 2016

Primary Completion Date

March 22, 2017

Study Completion Date

March 22, 2017

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

nintedanib

DRUG

pirfenidone

Trial Locations (9)

BS10 5NB

Southmead Hospital, Bristol

CB23 3RE

Papworth Hospital, Cambridge

LE3 9QP

Glenfield Hospital, Leicester

NW1 2PG

University College London Hospital, London

SE1 9RT

Guy's Hospital, London

SW3 6NP

Royal Brompton Hospital, London

M23 9LT

Wythenshawe Hospital, Manchester

OX3 7LE

Churchill Hospital, Oxford

SO16 6YD

Southampton General Hospital, Southampton

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02606877 - A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination | Biotech Hunter | Biotech Hunter